Literature DB >> 16965705

West Nile virus epizootiology, central Red River Valley, North Dakota and Minnesota, 2002-2005.

Jeffrey A Bell1, Christina M Brewer, Nathan J Mickelson, Gabriel W Garman, Jefferson A Vaughan.   

Abstract

West Nile virus (WNV) epizootiology was monitored from 2002 through 2005 in the area surrounding Grand Forks, North Dakota. Mosquitoes were tested for infection, and birds were surveyed for antibodies. In 2003, WNV was epidemic; in 2004, cool temperatures precluded WNV amplification; and in 2005, immunity in passerines decreased, but did not preclude, WNV amplification.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16965705      PMCID: PMC3291223          DOI: 10.3201/eid1208.060129

Source DB:  PubMed          Journal:  Emerg Infect Dis        ISSN: 1080-6040            Impact factor:   6.883


West Nile virus (WNV) is a flavivirus with an enzootic cycle that involves primarily mosquitoes and birds in the order Passeriformes. Since its introduction into the northern prairies of the United States in 2002, WNV has flourished. In 2003 and 2005, the prairie states of North Dakota, South Dakota, and Nebraska recorded the highest incidence of cases in humans (per 100,000 county residents) for the entire United States (). Although WNV is still new to the region, the ecology of the northern prairie seems to offer favorable conditions for its continued enzootic transmission. This report chronicles the initial establishment of WNV within the central Red River Valley of eastern North Dakota and northwestern Minnesota (Figure).
Figure

Red River Valley of North Dakota, Minnesota, and Manitoba.

Red River Valley of North Dakota, Minnesota, and Manitoba.

The Study

Host-seeking mosquitoes were collected in and around Grand Forks, North Dakota, by using Mosquito Magnet traps (American Biophysics Corp., North Kingston, RI, USA) for 4 transmission seasons, from early summer 2002 through fall 2005. Mosquitoes were sorted by species and tested for WNV by using reverse transcriptase PCR assays. WNV was detected only in Culex tarsalis (). Passerine birds in and around Grand Forks were surveyed for antibodies to WNV for 3 transmission seasons: June 24–October 27, 2003, April 4–July 7, 2004, and May 17–August 11, 2005. In 2003 and early 2004, birds were captured by using mist nets, blood (<0.1 mL) was obtained by brachial venipuncture, and birds were released. Later in 2004 and in 2005, necropsies were performed on dead birds. Blood spots were placed on filter paper and later eluted in 250 μL saline. Samples were tested for anti-WNV antibodies by using a qualitative epitope-blocking ELISA (). This is the first report of seroprevalence of WNV in passerines in the northern prairies. A total of 277 birds (11 species) were tested (Table 1). In 2003, seroprevalence was relatively low (17%). The first seropositive bird was captured July 24, 2003, 4 days after the first WNV-positive pool of Cx. tarsalis was detected (). Most seropositive birds (11 of 14) were collected in September, when migratory species were leaving and vector populations were waning. Thus, a lag occurred between peak abundance of infected vectors in mid- to late August 2003 () and seroconversion of passerines. Seroprevalence rates were significantly higher in 2004 and 2005 than in 2003 (Table 1, Fisher exact tests, p<0.0001) and were higher than most seroprevalences reported for passerines in the eastern and southeastern regions of the United States (–). All passerine species sampled in 2004 and 2005 contained seropositive birds, which indicated that all these species were preyed on by vectors regardless of differences in their nesting habitats (e.g., cattail marshes, peridomestic). American robins, common grackles, and red-winged blackbirds showed increased seroprevalence from 2003 to 2004. High seroprevalence was maintained in passerines in 2005 despite low WNV activity (i.e., low natural boosting) during 2004 (), which suggests that passerine immunity to WNV may last longer than a single season (,).
Table 1

Prevalence of antibodies against West Nile virus (WNV) in 11 species of passerine birds sampled within the central Red River Valley of North Dakota and Minnesota during 2003, 2004, and 2005

Common nameScientific name% birds with antibodies to WNV (n)
200320042005
American crow Corvus brachyrhynchos 33 (6)50 (6)
American robin Turdis migratorius 18 (17)50 (6)38 (26)
Brown-headed cowbird Molothrus ater 17 (6)
Blue jay Cyanocitta cristata 50 (4)87 (8)
Brewer's blackbird Euphagus cyanocephalus 33 (3)
Common grackle Quiscalus quiscula 0 (11)71 (14)63 (67)
Eastern kingbird Tyrannus tyrannus 100 (3)
European starling Sturnus vulgaris 100 (2)67 (3)
Gray catbird Dumetella carolinensis 75 (4)
House sparrow Passer domesticus 20 (45)50 (2)
Red-winged blackbird Agelaius phoeniceus 0 (5)50 (20)63 (19)
Total17.1 (82)57.7 (52)57.3 (143)
Surprisingly, American crows had a high seroprevalence to WNV. Previous laboratory and field studies have indicated that most American crows die so quickly from WNV infection that they never have time to seroconvert (–). Why crows in the Red River Valley survive WNV infection is not known. One possibility is that WNV has undergone genetic changes with a concurrent loss in virulence as it spread westward from forest ecosystems with Cx. pipiens with Cx. restuans as its primary vectors into prairie ecosystems and Cx. tarsalis as its primary vector (,,). Annual data on seroprevalence in passerines, environmental temperatures, reporting of human cases, and minimum infection rates (MIR) in vector populations are summarized in Table 2.
Table 2

Epizootiology of West Nile virus (WNV) within the central Red River Valley of North Dakota and Minnesota during the first 4 years of its introduction into the region*

YearPrimary transmission season†Thermal accumulations (degree-days)‡Vector abundance§Human cases in ND¶Seasonal MIR#Passerine seroprevalence
2002, introductory92 days
(11 Jun–10 Sep)1,067230170.0
(n = 5,871)No birds tested
2003, epidemic92 days
(11 Jun–10 Sep)1,022216175.7
(n = 5,432)17%
(n = 82)
2004, cold51 days
(7 Jul–1 Sep)3719200.0
(n = 1,245)58%
(n = 52)
2005, equilibrium?84 days
(20 Jun–11 Sep)86729861.3
(n = 3,123)57%
(n = 143)

*ND, North Dakota; MIR, minimum infection rate.
†Time between first and last appearances of host-seeking Culex tarsalis mosquitoes in Mosquito Magnet traps.
‡Based on developmental threshold temperature of 14.3°C for WNV growth in Cx. tarsalis ().
§Average number of Cx. tarsalis mosquitoes captured per trap-night in Grand Forks, ND.
¶Data from North Dakota Department of Public Health ().
#No. of WNV-infected Cx. tarsalis mosquitoes per 1,000.

*ND, North Dakota; MIR, minimum infection rate.
†Time between first and last appearances of host-seeking Culex tarsalis mosquitoes in Mosquito Magnet traps.
‡Based on developmental threshold temperature of 14.3°C for WNV growth in Cx. tarsalis ().
§Average number of Cx. tarsalis mosquitoes captured per trap-night in Grand Forks, ND.
¶Data from North Dakota Department of Public Health ().
#No. of WNV-infected Cx. tarsalis mosquitoes per 1,000.

Conclusions

Environmental conditions from 2002 to 2005 produced a natural field experiment, which demonstrated the differing magnitudes by which environmental temperature and host immunity affected local WNV activity. Despite warm temperatures and high vector abundance, WNV activity was low during its introductory year (2002), as indicated by low numbers of human cases, undetectably low seasonal MIR, and by low seroprevalence in passerines in 2003. Because WNV had only recently arrived, presumably there was neither sufficient time nor number of infection nidi to promote extensive amplification cycles. However, 2003 was an epidemic year for WNV, as indicated by the increased number of human cases statewide and the high MIR in the local vector population. The relatively low level of immunity in passerines at the time also likely contributed to the epidemic. In 2004, unusually cool environmental temperatures prolonged vector larval development, adult emergence, and the arboviral extrinsic incubation period. As a result, duration of the 2004 transmission season was nearly half that of the preceding seasons (Table 2). Thus, WNV activity during 2004 was low (i.e., reduced vector abundance, number of human cases, and seasonal MIR), and the virus had insufficient time to undergo extensive amplification cycles, similar to the situation that occurred during the introductory year of 2002. However, the epidemic conditions of 2003 had produced a high level of herd immunity in the local bird population in 2004. This immunity carried over into 2005. (Note: most migratory passerine species live for several years and return each year to the same general locale to breed.) In 2005, environmental temperature, length of transmission season, and vector abundance were all nearly identical to those of the epidemic year of 2003. Yet the intensity of WNV activity during 2005 was considerably less than that during 2003. The big difference between 2003 and 2005 was the level of immunity in passerines. The high prevalence of immunity during 2005 may have contributed to preventing another epidemic, but it did not totally eliminate WNV activity. Levels of WNV activity during 2005 (as measured by human cases and mosquito MIR) were intermediate between those of the epidemic year (2003) and both the introductory year (2002) and the coldest year (2004). Thus, environmental temperature dictated the ultimate success (or more precisely, the failure) of WNV amplification within the central Red River Valley during 2004, whereas even high levels of herd immunity among the reservoir population exerted only a moderating effect on WNV activity during 2005. Whether the level of WNV activity observed during 2005 will be representative of the arbovirus's natural equilibrium within the central Red River Valley remains to be seen. One uncertainty is how seasonal transmission is initiated. Is WNV reintroduced every spring through infected migratory birds or wind-blown mosquitoes from the south? Or does WNV survive the harsh winters inside mosquitoes undergoing diapause, only to reemerge in the spring? Either or both of these scenarios could be correct, but one conclusion is certain: the incidence of WNV disease in horses from North Dakota during June of 2002 and again in May of 2005 () indicates that WNV becomes active in the northern Great Plains well in advance of the first summer brood of its primary vector, Cx. tarsalis ().
  12 in total

1.  West Nile virus epizootiology in the southeastern United States, 2001.

Authors:  Marvin S Godsey; Mark S Blackmore; Nicholas A Panella; Kristen Burkhalter; Kristy Gottfried; Lawrence A Halsey; Roxanne Rutledge; Stanley A Langevin; Robert Gates; Karen M Lamonte; Amy Lambert; Robert S Lanciotti; Carina G M Blackmore; Tom Loyless; Lillian Stark; Robin Oliveri; Lisa Conti; Nicholas Komar
Journal:  Vector Borne Zoonotic Dis       Date:  2005       Impact factor: 2.133

2.  Epitope-blocking enzyme-linked immunosorbent assays for the detection of serum antibodies to west nile virus in multiple avian species.

Authors:  Bradley J Blitvich; Nicole L Marlenee; Roy A Hall; Charles H Calisher; Richard A Bowen; John T Roehrig; Nicholas Komar; Stanley A Langevin; Barry J Beaty
Journal:  J Clin Microbiol       Date:  2003-03       Impact factor: 5.948

3.  Antibody response of wild birds to natural infection with alphaviruses.

Authors:  John J Howard; Joanne Oliver; Margaret A Grayson
Journal:  J Med Entomol       Date:  2004-11       Impact factor: 2.278

4.  Changes in seroprevalence of West Nile virus across Illinois in free-ranging birds from 2001 through 2004.

Authors:  Tara A Beveroth; Michael P Ward; Richard L Lampman; Adam M Ringia; Robert J Novak
Journal:  Am J Trop Med Hyg       Date:  2006-01       Impact factor: 2.345

5.  Persistence of antibodies to West Nile virus in naturally infected rock pigeons (Columba livia).

Authors:  Samantha E J Gibbs; Douglas M Hoffman; Lillian M Stark; Nicole L Marlenee; Bradley J Blitvich; Barry J Beaty; David E Stallknecht
Journal:  Clin Diagn Lab Immunol       Date:  2005-05

6.  Effects of temperature on the transmission of west nile virus by Culex tarsalis (Diptera: Culicidae).

Authors:  William K Reisen; Ying Fang; Vincent M Martinez
Journal:  J Med Entomol       Date:  2006-03       Impact factor: 2.278

7.  Serologic evidence for West Nile virus infection in birds in Staten Island, New York, after an outbreak in 2000.

Authors:  N Komar; J Burns; C Dean; N A Panella; S Dusza; B Cherry
Journal:  Vector Borne Zoonotic Dis       Date:  2001       Impact factor: 2.133

8.  West Nile virus and high death rate in American crows.

Authors:  Sarah A Yaremych; Richard E Warner; Phil C Mankin; Jeff D Brawn; Arlo Raim; Robert Novak
Journal:  Emerg Infect Dis       Date:  2004-04       Impact factor: 6.883

9.  Genetic variation among temporally and geographically distinct West Nile virus isolates, United States, 2001, 2002.

Authors:  C Todd Davis; David W C Beasley; Hilda Guzman; Rushker Raj; Mary D'Anton; Robert J Novak; Thomas R Unnasch; Robert B Tesh; Alan D T Barrett
Journal:  Emerg Infect Dis       Date:  2003-11       Impact factor: 6.883

10.  Experimental infection of North American birds with the New York 1999 strain of West Nile virus.

Authors:  Nicholas Komar; Stanley Langevin; Steven Hinten; Nicole Nemeth; Eric Edwards; Danielle Hettler; Brent Davis; Richard Bowen; Michel Bunning
Journal:  Emerg Infect Dis       Date:  2003-03       Impact factor: 6.883

View more
  18 in total

1.  DIFFERENTIAL IMPACT OF WEST NILE VIRUS ON CALIFORNIA BIRDS.

Authors:  Sarah S Wheeler; Christopher M Barker; Ying Fang; M Veronica Armijos; Brian D Carroll; Stan Husted; Wesley O Johnson; William K Reisen
Journal:  Condor       Date:  2009       Impact factor: 2.135

2.  Molecular identification of vertebrate and hemoparasite DNA within mosquito blood meals from eastern North Dakota.

Authors:  Joseph O Mehus; Jefferson A Vaughan
Journal:  Vector Borne Zoonotic Dis       Date:  2013-10-09       Impact factor: 2.133

3.  Epidemiology of West Nile virus in the highly epidemic state of North Dakota, 2002-2007.

Authors:  Stephanie M Borchardt; Michelle A Feist; Tracy Miller; Tze Shien Lo
Journal:  Public Health Rep       Date:  2010 Mar-Apr       Impact factor: 2.792

4.  Assessing the risks of West Nile virus-infected mosquitoes from transatlantic aircraft: implications for disease emergence in the United Kingdom.

Authors:  Eleanor B E Brown; Amie Adkin; Anthony R Fooks; Ben Stephenson; Jolyon M Medlock; Emma L Snary
Journal:  Vector Borne Zoonotic Dis       Date:  2012-01-04       Impact factor: 2.133

5.  Predictive risk mapping of West Nile virus (WNV) infection in Saskatchewan horses.

Authors:  Tasha Y Epp; Cheryl Waldner; Olaf Berke
Journal:  Can J Vet Res       Date:  2011-07       Impact factor: 1.310

6.  Arboviruses in North Dakota, 2003-2006.

Authors:  John F Anderson; Andy J Main; Philip M Armstrong; Theodore G Andreadis; Francis J Ferrandino
Journal:  Am J Trop Med Hyg       Date:  2014-12-08       Impact factor: 2.345

7.  West Nile virus in American White Pelican chicks: transmission, immunity, and survival.

Authors:  Marsha A Sovada; Pamela J Pietz; Erik K Hofmeister; Alisa J Bartos
Journal:  Am J Trop Med Hyg       Date:  2013-03-25       Impact factor: 2.345

8.  Spatio-temporal cluster analysis of county-based human West Nile virus incidence in the continental United States.

Authors:  Ramanathan Sugumaran; Scott R Larson; John P Degroote
Journal:  Int J Health Geogr       Date:  2009-07-13       Impact factor: 3.918

9.  West Nile virus antibodies in permanent resident and overwintering migrant birds in south-central Kansas.

Authors:  Thomas R Shelite; Christopher M Rogers; Brandon R Litzner; R Roy Johnson; Mark A Schneegurt
Journal:  Vector Borne Zoonotic Dis       Date:  2008-06       Impact factor: 2.133

10.  Epidemic West Nile Virus Infection Rates and Endemic Population Dynamics Among South Dakota Mosquitoes: A 15-yr Study from the United States Northern Great Plains.

Authors:  Geoffrey P Vincent; Justin K Davis; Matthew J Wittry; Michael C Wimberly; Chris D Carlson; Denise L Patton; Michael B Hildreth
Journal:  J Med Entomol       Date:  2020-05-04       Impact factor: 2.278

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.